Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Jacob S. Hodskins

Hematology Oncology | Hematology | Oncology
Owensboro Health, Inc
1006 Ford Ave, 
Owensboro, KY 
Offers Telehealth

Experienced in WT1-Related Wilms Tumor Syndromes
Owensboro Health, Inc
1006 Ford Ave, 
Owensboro, KY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jacob Hodskins is a Hematologist Oncology specialist and a Hematologist in Owensboro, Kentucky. Dr. Hodskins is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Small Cell Lung Cancer (SCLC).

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in KY
Hospital Affiliations
Ohio County Hospital
Owensboro Health Muhlenberg Community Hospital
Owensboro Health Regional Hospital
Perry County Memorial Hospital
Owensboro Health Twin Lakes Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

OWENSBORO HEALTH, INC
1006 Ford Ave, Owensboro, KY 42301
Call: 270-688-4845
Other Locations
OWENSBORO HEALTH MEDICAL GROUP INC
1000 Breckenridge St, Suite 201, Owensboro, KY 42303
Call: 270-688-3445

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients With Previously Treated Non-Squamous NSCLC
A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients With Previously Treated Non-Squamous NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Procedure, Drug, Biological
Study Drugs: Cabozantinib S-malate, Docetaxel, Gemcitabine Hydrochloride, Nab-paclitaxel, Nivolumab, Paclitaxel, Ramucirumab
Study Phase: Phase 2
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Other
Study Phase: Phase 3
A Phase II Randomized Study of Ramucirumab Plus MK3475 (Pembrolizumab) Versus Standard of Care for Patients Previously Treated With Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)
A Phase II Randomized Study of Ramucirumab Plus MK3475 (Pembrolizumab) Versus Standard of Care for Patients Previously Treated With Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)
Enrollment Status: Completed
Publish Date: September 03, 2024
Intervention Type: Drug, Biological
Study Drugs: Docetaxel, Gemcitabine, Gemcitabine Hydrochloride, Pembrolizumab, Pemetrexed, Pemetrexed Disodium, Ramucirumab
Study Phase: Phase 2
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: April 05, 2023
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
View 3 Less Clinical Trials

3 Total Publications

Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy.
Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy.
Journal: BMC cancer
Published: April 24, 2017
View All 3 Publications
Similar Doctors
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Karim Anwar
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Karim Anwar
Hematology Oncology | Hematology | Oncology

Little Company Of Mary Hospital Of Indiana Inc

600 W 13th St, 
Jasper, IN 
 (45.6 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Karim Anwar is a Hematologist Oncology specialist and a Hematologist in Jasper, Indiana. Dr. Anwar is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Familial Colorectal Cancer, Lynch Syndrome, Colorectal Cancer, and Small Cell Lung Cancer (SCLC). Dr. Anwar is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Maqbool A. Ahmed
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Maqbool A. Ahmed
Hematology Oncology | Hematology | Oncology

Gibson General Hospital Inc

1808 Sherman Dr, Suite 2209, 
Princeton, IN 
 (49.1 miles away)
812-385-9420
Languages Spoken:
English, Punjabi, Urdu
See accepted insurances
Accepting New Patients

Maqbool Ahmed is a Hematologist Oncology specialist and a Hematologist in Princeton, Indiana. Dr. Ahmed is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Familial Colorectal Cancer, and Lung Cancer. Dr. Ahmed is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Stephen R. Toothaker
Oncology | Hematology Oncology | Hematology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Stephen R. Toothaker
Oncology | Hematology Oncology | Hematology

Little Company Of Mary Hospital Of Indiana Inc

600 W 13th St, 
Jasper, IN 
 (45.6 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Stephen Toothaker is an Oncologist and a Hematologist Oncology provider in Jasper, Indiana. Dr. Toothaker is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Large-Cell Lung Carcinoma, and Lung Adenocarcinoma. Dr. Toothaker is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hodskins's expertise for a condition
ConditionClose
    • Distinguished
    • Childhood Iron Deficiency Anemia
      Dr. Hodskins is
      Distinguished
      . Learn about Childhood Iron Deficiency Anemia.
      See more Childhood Iron Deficiency Anemia experts
    • Colorectal Cancer
      Dr. Hodskins is
      Distinguished
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Familial Colorectal Cancer
      Dr. Hodskins is
      Distinguished
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    • Lung Cancer
      Dr. Hodskins is
      Distinguished
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    • Pleuropulmonary Blastoma
      Dr. Hodskins is
      Distinguished
      . Learn about Pleuropulmonary Blastoma.
      See more Pleuropulmonary Blastoma experts
    • Small Cell Lung Cancer (SCLC)
      Dr. Hodskins is
      Distinguished
      . Learn about Small Cell Lung Cancer (SCLC).
      See more Small Cell Lung Cancer (SCLC) experts
    • Advanced
    • Acute Mountain Sickness
      Dr. Hodskins is
      Advanced
      . Learn about Acute Mountain Sickness.
      See more Acute Mountain Sickness experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Hodskins is
      Advanced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Anal Cancer
      Dr. Hodskins is
      Advanced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Anemia
      Dr. Hodskins is
      Advanced
      . Learn about Anemia.
      See more Anemia experts
    • Angiosarcoma
      Dr. Hodskins is
      Advanced
      . Learn about Angiosarcoma.
      See more Angiosarcoma experts
    • B-Cell Lymphoma
      Dr. Hodskins is
      Advanced
      . Learn about B-Cell Lymphoma.
      See more B-Cell Lymphoma experts
    View All 25 Advanced Conditions
    • Experienced
    • 2q37 Deletion Syndrome
      Dr. Hodskins is
      Experienced
      . Learn about 2q37 Deletion Syndrome.
      See more 2q37 Deletion Syndrome experts
    • 47 XYY Syndrome
      Dr. Hodskins is
      Experienced
      . Learn about 47 XYY Syndrome.
      See more 47 XYY Syndrome experts
    • Aase Syndrome
      Dr. Hodskins is
      Experienced
      . Learn about Aase Syndrome.
      See more Aase Syndrome experts
    • Abruzzo-Erickson Syndrome
      Dr. Hodskins is
      Experienced
      . Learn about Abruzzo-Erickson Syndrome.
      See more Abruzzo-Erickson Syndrome experts
    • Acrodermatitis Enteropathica
      Dr. Hodskins is
      Experienced
      . Learn about Acrodermatitis Enteropathica.
      See more Acrodermatitis Enteropathica experts
    • Acrorenal Mandibular Syndrome
      Dr. Hodskins is
      Experienced
      . Learn about Acrorenal Mandibular Syndrome.
      See more Acrorenal Mandibular Syndrome experts
    View All 205 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved